Journey Medical DERM
NASDAQ DERM
$7.47 +0.66 (+9.69%)
At close: Aug 20, 2026 · 1:48 PM UTC

Journey Medical (DERM) Raw Materials (2021)

Journey Medical's (DERM) quarterly Raw Materials came in at $5.6 million in Q4 2021, up 2.18% on a QoQ basis from $5.5 million in Q3 2021.

Journey Medical (DERM) Raw Materials (2021) Analysis & Trends

Journey Medical (DERM) has 1 years of Raw Materials data on file, last reported at $5.6 million in Q4 2021.

  • Quarterly Raw Materials changed N/A year-over-year to $5.6 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $5.6 million (changed N/A YoY) and the FY2021 annual result came in at $5.6 million, changed N/A from the prior year.
  • Raw Materials climbed to $5.6 million in Q4 2021, from $5.5 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $5.6 million in Q4 2021 to a low of $5.5 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 Journey Medical 205.38 Mn 179.73 Mn 12.37 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 5.57 Mn
Sep 30, 2021 5.45 Mn